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Cardiovascular autonomic control in mice lacking angiotensin AT1a
receptors. Am J Physiol Regul Integr Comp Physiol 288: R1071–
R1077, 2005. First published December 2, 2004; doi:10.1152/ajpregu.
00231.2004.—Studies examined the role of angiotensin (ANG) AT1a
receptors in cardiovascular autonomic control by measuring arterial
pressure (AP) and heart rate (HR) variability and the effect of
autonomic blockade in mice lacking AT1a receptors (AT1a /).
Using radiotelemetry in conscious AT1a / and AT1a / mice,
we determined 1) AP and pulse interval (PI) variability in time and
frequency (spectral analysis) domains, 2) AP response to 1-adrener-
gic and ganglionic blockade, and 3) intrinsic HR after ganglionic
blockade. Pulsatile AP was recorded (5 kHz) for measurement of AP
and PI and respective variability. Steady-state AP responses to pra-
zosin (1 g/g ip) and hexamethonium (30 g/g ip) were also mea-
sured. AP was lower in AT1a / vs. AT1a /, whereas HR was
not changed. Prazosin and hexamethonium produced greater de-
creases in mean AP in AT1a / than in AT1a /. The blood
pressure difference was marked after ganglionic blockade (change in
mean AP of 44  10 vs. 18  2 mmHg, AT1a / vs. AT1a
/ mice). Intrinsic HR was also lower in AT1a / mice (431 
32 vs. 524  22 beats/min, AT1a / vs. AT1a /). Beat-by-beat
series of systolic AP and PI were submitted to autoregressive spectral
estimation with variability quantified in low-frequency (LF: 0.1–1 Hz)
and high-frequency (HF: 1–5 Hz) ranges. AT1a / mice showed a
reduction in systolic AP LF variability (4.3  0.8 vs. 9.8  1.3
mmHg2), with no change in HF (2.7  0.3 vs. 3.3  0.6 mmHg2).
There was a reduction in PI variability of AT1a / in both LF
(18.7  3.7 vs. 32.1  4.2 ms2) and HF (17.7  1.9 vs. 40.3  7.3
ms2) ranges. The association of lower AP and PI variability in AT1a
/ mice with enhanced AP response to 1-adrenergic and gangli-
onic blockade suggests that removal of the ANG AT1a receptor
produces autonomic imbalance. This is seen as enhanced sympathetic
drive to compensate for the lack of ANG signaling.
heart rate; blood pressure; baroreflex; autonomic nervous system;
spectral analysis
GENETICALLY MANIPULATED ANIMAL models have been exten-
sively used to study the physiological role of the renin-angio-
tensin system (RAS) in the control of arterial pressure (AP),
cardiac function, and fluid homeostasis (2, 12, 13). Despite
some drawbacks, the deletion or overexpression of a specific
gene for any component of the RAS provides a unique way to
understand the role of the RAS not only in cardiovascular
development and function but also in pathological processes. It
is widely accepted that the RAS is important in the mainte-
nance of normal AP levels. It contributes to the development of
hypertension, not only by direct vasoconstrictor actions of
angiotensin II (ANG II) but also via ANG II effects on the
central nervous system to increase sympathetic drive to the
heart and vasculature (53). Recent studies in AT1a receptor
gene-deletion mice have demonstrated the importance of these
receptors in the maintenance of body fluid homeostasis (8, 14,
37, 45), blood pressure (11, 22, 36), and endocrine function
(34, 35, 38). Support for a cardiovascular role of the comple-
mentary AT1b receptor was provided by data that showed that
losartan lowered AP in AT1a / mice (36), that hypotension
was enhanced in the combined AT1a/AT1b gene deletion
model (39), and that AT1b receptors produce vasoconstriction
in resistance vessels (50).
Interactions between the RAS and autonomic nervous sys-
tem have been well documented (53). For example, ANG II
increases sympathetic nerve activity, stimulates norepinephrine
release, and directly activates sympathetic ganglionic cells,
effects that may be mediated by AT1 receptors (6, 27, 28, 42,
47). Studies that used ANG AT1 receptor and converting
enzyme antagonists suggest that the RAS is also involved in
autonomic balance (4, 21, 32). For example, Bezerra et al. (4)
reported that AT1 receptors were involved in the autonomic
changes associated with coarctation hypertension in rats, acting
to facilitate sympathetic outflow to the heart and vasculature.
In healthy humans, treatment with an AT1 antagonist reduced
HR variability, an effect that was thought to be mediated by
increased plasma ANG II (21). A critical lack in our knowl-
edge base is related to the role of the AT1a subtype-specific
receptors in autonomic balance.
The cardiovascular effects of pharmacological blockade of
cholinergic/adrenergic receptors and autonomic ganglionic
transmission as well as measurement of neural activity and
baroreflex sensitivity are useful tools for assessment of auto-
nomic influences on the heart and vasculature (19). However,
all of these tests are invasive and difficult to standardize. A
recent advance in the study of autonomic function has been the
development of methods for the evaluation of pulse interval
(PI) and AP variability in time and frequency domains (1, 3,
31, 40). AP and PI fluctuate at regular frequencies, and the
magnitude of each can be accurately quantified by the use of
power spectral analysis. With simple measurement and pro-
cessing of AP data under baseline conditions, information on
autonomic influences on the heart and vessels is available.
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These methods have been applied successfully to the mouse
model with evaluation of the input of autonomic transmitters
(20, 23–25).
Experiments were conducted to evaluate the role of ANG
AT1a receptors in the control of cardiovascular autonomic
function with high-fidelity telemetric AP recordings in con-
scious ANG AT1a gene-deletion mice coupled with autore-
gressive spectral analysis and autonomic blockade. To our
knowledge, this is the first study to examine ANG AT1a
subtype-specific involvement in autonomic function. The aims
are to determine 1) AP and heart rate (HR) variabilities in time
and frequency domains, 2) spontaneous baroreflex sensitivity,
3) AP response to 1-adrenergic blockade with prazosin, and
4) AP and HR responses to total ganglionic blockade with
hexamethonium.
MATERIALS AND METHODS
Animals. Male ANG AT1a receptor knockout mice (AT1a /,
n  26) and wild-type controls (AT1a /, n  25) were used in the
present study. The founder animals were developed by Ito et al. (22),
and the original breeders were obtained from T. Coffman (Duke
University, Durham, NC). F2 generation mice were produced from
crosses of (129  C57BL/6J) F1 AT1a / parents. Experimental
animals had the same genetic and environmental backgrounds. Geno-
types were determined with DNA from tail extracts and PCR methods.
The animals (26 g) were housed individually at 22°C on a 12:12-h
dark-light cycle. They were fed a standard pellet diet (Harlan-Teklad
8640, 0.4% sodium by weight) with tap water ad libitum. The
Laboratory Animal Care and Use Committee of Wright State Univer-
sity approved all experimental protocols.
Surgical procedures. Under ketamine-xylazine mixture anesthesia
(120:20 mg/kg im), radiotelemetric catheters (model TA11PA-C20,
Data Sciences International, St. Paul, MN) were inserted into the
carotid artery. The methods have been previously described in detail
(17). Briefly, the left common carotid artery was isolated, ligated (3
mm below the carotid bifurcation), and occluded; the catheter was
then inserted into the artery. The telemetric transmitter probe was
positioned subcutaneously on the right flank. Mice were returned to
their home cages, which were placed on top of the telemetric receivers.
Cardiovascular recording. Recordings were carried out after the
mice had fully recovered from surgery (5–7 days). On the day of the
experiment, the telemetric probe was magnetically activated at least
1 h before initiation of recording (08:00 h). Pulsatile arterial
pressure (PAP) was continuously sampled (5 kHz) for 1 h with the use
of an IBM/PC interfaced with the telemetry system. Only animals
with a PAP amplitude of 	30 mmHg were included in the study
(example in Fig. 1).
Experimental protocols. AP, HR, and their respective variabilities,
as well as spontaneous baroreflex sensitivity, were measured in AT1a
/ and AT1a / mice (n  13–14/group) with an AP recording
(continuous 1 h) made under low-stress conditions. Other groups
(AT1a / and AT1a /) were used to test the effects of prazosin
(1 g/g; Sigma-Aldrich; 7/group) and hexamethonium chloride (30
g/g; Sigma-Aldrich; 5/group). AP recordings were made 30–60 min
after intraperitoneal injection.
Data analysis. PAP files of the entire 1-h recording were analyzed
by software (CODAS, Dataq Instruments, Akron, OH) that detects
beat-by-beat values of systolic AP (SAP). PI series were generated
from the intervals between successive SAP values. The variances of
the PI and SAP series were calculated (time domain). The variabilities
of PI and SAP were also evaluated in the frequency domain using an
autoregressive spectral estimation according to methods described
elsewhere (16, 31). Briefly, PI and SAP series were divided into 300
beat segments, overlapped by 50%, and the spectrum of each segment
was calculated via the Levinson-Durbin recursion, with the model
order chosen according to Akaike’s criterion. The oscillatory compo-
nents found by spectral analysis were quantified into low-frequency
(LF: 0.1–1.0 Hz) and high-frequency (HF: 1.0–5.0 Hz) bands. The
coherence between the oscillatory components of PI and SAP in LF
range was estimated by bivariate autoregressive spectral analysis (3).
Coherence is a measurement of the statistical link between the
variability of two series at any given frequency and is expressed as a
number between 0 (total lack of relationship) and 1 (maximum
relationship). Only values 	0.5 were considered significant (3, 44).
When the oscillations of SAP and PI in LF range were found to be
coherent, the -index was calculated by the square root of the ratio
between spectral density of PI and the corresponding spectral density
of SAP, as first described by Robbe et al. (43). The presence of a
significant coherence between PI and SAP oscillations in the LF range
and the -index are both an expression of the spontaneous baroreflex
control of HR (3, 16, 20).
Spontaneous baroreflex sensitivity was also calculated in each
recording period by means of the sequence analysis technique, as
described elsewhere (20, 26). Briefly, we used software that automat-
ically detected sequences of three or more consecutive beats in time
series of SAP and PI, with delays of about zero to four beats
determined by cross-correlation between the AP and PI series. These
sequences were characterized either by a progressive rise in AP and
lengthening of PI (PI/SAP sequences) or by a progressive de-
crease in SAP and shortening PI (PI/SAP sequences) with linear
correlation higher than 0.8. The mean individual slope of significant
SAP/PI relationship obtained by averaging all slopes computed within
the test period was calculated and taken as a measure of spontaneous
baroreflex sensitivity.
To determine the AP response to 1-adrenergic and ganglionic
blockade, mean AP (MAP) was calculated from the AP signals. The
steady-state responses to prazosin or hexamethonium were deter-
mined (30–40 min after intraperitoneal injection) and shown as the
change from baseline levels (
MAP). Because hexamethonium abol-
ishes both vagal and sympathetic influences to the heart (49), we
considered the intrinsic pacemaker rate to be the HR value achieved
after hexamethonium injection.
Fig. 1. Telemetric recordings of pulsatile arterial pressure (AP) from a repre-
sentative mouse of each group. Top: wild-type control (AT1a /) mouse.
Bottom: ANG AT1a receptor knockout (AT1a /) mouse. White lines
represent the mean arterial pressure (MAP).
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Statistical analysis. Results are expressed as means  SE. Basal
values of SAP and PI were compared between groups by Student’s
t-test. All parameters of variability in time or frequency domain, as
well as baroreflex indexes and MAP responses to administration of
prazosin and hexamethonium, were compared between groups by the
nonparametric Mann-Whitney on rank test. Differences were consid-
ered statistically significant if P  0.05.
RESULTS
Figure 1 shows representative PAP tracings of one animal
from each group studied. The AT1a / mouse exhibits
hypotension compared with its AT1a / control. The reduc-
tion in mean AP variability in the AT1a / mouse is clearly
seen by comparing the mean AP tracings (white line in Fig. 1).
Group data show that AT1a / mice have significantly
reduced MAP compared with AT1a / controls [82  3 vs.
99  3 mmHg (AT1a/ vs. AT1a/); P  0.001]. HR
was similar in groups [475  11 vs. 487  10 beats/min
(AT1a/ vs. AT1a /); P  0.42].
Table 1 shows group data for baseline PI and SAP, as well
as their respective variances. PI is not different between
groups, whereas the PI variance is significantly lower in AT1a
/ compared with AT1a / mice. AT1a / mice also
showed lower levels of SAP and its variance.
Representative time series and respective autoregressive
spectra for PI and SAP from one animal of each group are
shown in Fig. 2. Both time series presented visible variability,
which could be discriminated in two distinct oscillatory com-
ponents by spectral analysis. PI spectra showed LF (0.43–0.45
Hz) and HF (2.69–2.81 Hz) peaks, which were not different
between groups. Frequencies of SAP oscillations were similar
to those found for the PI spectra (data not shown). Figure 3
shows the group data for LF and HF power for PI and SAP
oscillations. There were significantly lower PI and SAP fluc-
tuations in the LF range for the AT1a / group (more than
2-fold). The HF component of variability in AT1a / mice
was reduced power for PI but not for SAP (Fig. 3).
Spontaneous baroreflex sensitivity, calculated by the -in-
dex, was similar in AT1a/ and AT1a/ mice [3.5 0.4
vs. 3.1 0.4 ms/mmHg (AT1a/ vs. AT1a/); P 0.79].
Results were also similar when baroreflex function [3.2  0.3
vs. 4.2 0.5 ms/mmHg (AT1a/ vs. AT1a/); P 0.15]
was calculated using the sequence analysis method (Fig. 4).
1-Adrenergic blockade with prazosin produced a greater
depressor response in AT1a / mice [change of 24  3 vs.
9  2 mmHg (AT1a / vs. AT1a /); P  0.05; Fig. 5].
Ganglionic blockade with hexamethonium also elicited a
greater decrease in MAP in AT1a / (change of 44  10
mmHg) compared with AT1a / (change of 18  2 mmHg,
Fig. 5) mice. The bradycardia elicited by hexamethonium was
more pronounced in AT1a / mice [431  32 vs. 524  22
beats/min (AT1a / vs. AT1a /); P  0.05; Fig. 6]. This
provides evidence for a reduced intrinsic HR (HR achieved
after ganglionic blockade) in mice lacking the AT1a receptor.
DISCUSSION
These results provide new information on the role of the
ANG AT1a receptor in the control of cardiovascular autonomic
function. Using two different methods, autoregressive analysis
of telemetric AP recordings and pharmacological blockade, we
Table 1. Baseline values of PI and SAP of both groups
(ATIa / and ATIa /) and their respective indexes of
variability in the time domain (variance)
AT1a / AT1a / P Value
PI, ms 1333 1263 0.23
PI var, ms2 82.312.0 37.12.6* 0.001
SAP, mmHg 1236 963* 0.001
SAP var, mmHg2 14.21.6 8.01.0* 0.005
Values are means  SE. AT1a /, wild-type control mice; AT1a /,
ANG AT1a receptor knockout mice; PI, pulse interval; SAP, systolic arterial
pressure; var, variance. *P  0.05 vs. AT1a / mice.
Fig. 2. Left and middle: time series of pulse interval (PI) and systolic arterial pressure (SAP) from a representative mouse of each group (AT1a / and AT1a
/). Their respective spectra are shown in right panel.
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demonstrated an autonomic imbalance in mice lacking AT1a
receptors. In AT1a / mice, there was a marked reduction
(2-fold) in PI and SAP variability in the LF range. Blockade
of 1-adrenergic receptors or ganglionic transmission produced
an enhanced AP fall in AT1a / mice. Moreover, the
intrinsic HR, observed after ganglionic blockade, was lower in
AT1a/ mice compared with the controls. Data suggest that
increased sympathetic input acts to compensate for the lack of
ANG receptor signaling in AT1a /.
There is evidence supporting a role for AT1a receptors in the
maintenance of AP. In the original publication describing the
knockout model, Ito et al. reported that AT1a / mice
showed a reduction in SAP of 24 mmHg (22). In the present
study, MAP was reduced 17 mmHg in AT1a / mice.
However, although AT1a / mice are hypotensive, the AP
levels are not as low as one might predict, given the importance
of vascular ANG receptors. It has been suggested that AT1a
deficiency results in compensation by other systems. A feed-
back action is seen in the absence of AT1a receptors, a
situation in which ANG II secretion is stimulated (8). In
rodents, this ANG II could interact with other ANG receptors
to take over some of the functions of AT1a receptors (33, 36,
50, 52). This is supported by results showing an additional
depressor response in AT1a / mice treated with AT1
blockers (36). Zhu et al. (52) also suggested that AT1a and
non-AT1a receptors share common signal transduction path-
ways, since cultured smooth muscle cells from AT1a /
mice showed the same intracellular calcium changes in re-
sponse to the pharmacological stimulation with ANG II. In the
peripheral vasculature (aorta and femoral artery), there was
evidence for a predominance of AT1b subtypes as well as an
ANG II-induced vasoconstriction in AT1a / mice (50).
Finally, in the brain stem dorsal vagal complex, AT1b recep-
tors were higher in AT1a / mice and were upregulated in
response to dietary salt (9, 10).
Although there is much information on the role of AT1a
receptors in AP maintenance, there is less information on their
role in autonomic function. One of the best ways to answer this
question is to take advantage of an animal model that lacks the
ANG receptor signaling pathway. To our knowledge, this is the
first study to examine autonomic status in AT1a / mice, by
determining AP and HR variability and their spectral compo-
nents. HR and AP variabilities are used to estimate autonomic
modulation of the cardiovascular system in both clinical (1, 3,
31) and experimental settings (16, 20, 23, 24, 41, 44). Overall
variability indexes of HR and AP are strongly correlated with
autonomic modulation of the heart and vessels, whereas spec-
tral analysis of the intrinsic rhythms provides reliable informa-
tion on sympathetic and parasympathetic modulation (1, 3, 16,
20, 23). There is evidence that LF oscillations of HR variability
are a marker of sympathetic modulation, whereas HF oscilla-
tions are widely recognized as a marker of vagal modulation of
the sinus node (1, 31). In addition, spectral analysis applied to
spontaneous AP fluctuations has revealed, in humans and in
rats, that slow rhythms are modulated by sympathetic drive to
the heart and vasculature, which is also related to baroreflex
activity (3, 7, 15, 31, 44).
There is less information on autonomic modulation of car-
diovascular function in mice than in humans or other species.
Nevertheless, based on available reports, data in mice show
that HR and AP variability are influenced by sympathetic and
parasympathetic input (18, 20, 23, 25). Studies that used
spectral analysis in mice have revealed slow oscillations be-
tween 0.08 and 1.0 Hz and the higher respiratory frequency of
2.5–3.5 Hz, both for HR or AP series (17, 20, 24, 25). There
are also reports that autonomic blockers modify the power of
Fig. 3. Power spectral density of PI (left)
and SAP (right) for low-frequency (LF: 0.1–
1.0 Hz) and high-frequency (HF: 1.0–5.0
Hz) components of variability, calculated by
means of autoregressive spectral estimation.
Data show means SE. *P 0.05 vs. AT1a
/; #P  0.01 vs. AT1a /.
Fig. 4. Baroreflex sensitivity calculated using sequence analy-
sis (left) and cross-spectral analysis (-index, right) in AT1a
/ and AT1a / mice. E, Individual values.
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LF oscillations either in HR or AP series. Janssen et al. (23)
reported that both ganglionic and -adrenergic blockade de-
creased MAP variability; muscarinic blockade had no effect on
MAP fluctuations but decreased those of PI. Our group (18)
found similar results, although PI was reduced after atropine in
contrast to a lack of change in the Janssen study. The present
results showed lower variability in SAP and HR in both time
and frequency domains, suggesting changes in autonomic bal-
ance in AT1a / mice.
Studies have shown that LF for AP is associated with
sympathetic control of the vascular tone, as demonstrated by
acute pharmacological interventions or stress exposure (17, 18,
25). In AT1a / mice, chronic hypotension was associated
with a reduced LF for AP. On face value, this might indicate a
reduction in sympathetic input. However, studies in humans of
varying ages and gender showed no correlation between sym-
pathetic activity and LF power for AP (48). Likewise, our
group (17) found that chronic stress in rats was associated with
increased blood pressure but reduced LF power for AP. Re-
ports have also shown reduced LF oscillations of HR in
situations of high sympathetic tone (46, 49). Therefore, the
finding of reduced LF variability of SAP and PI in the present
study supports the idea of altered sympathetic modulation of
the cardiovascular system. However, based only on the spectral
analytic data, one cannot determine the degree of the sympa-
thetic tone. For HF oscillations of PI, there was also a reduction
in AT1a / mice, suggesting an impairment in cardiac vagal
modulation in these mice.
There is a body of evidence suggesting that the RAS inter-
acts with the sympathetic nervous system in the control of
circulation (42, 53). This interaction could involve a RAS
stimulatory effect on sympathetic activity at the level of the
central nervous system, sympathetic ganglia, or adrenergic
nerve terminals (42). The mechanisms of the RAS stimulatory
effects on sympathetic nerve activity involve ANG actions
mainly through ANG AT1 receptors (51). In mice, evidence
points to a significant stimulatory effect of ANG II on the
sympathetic nerve transmission. Ma et al. (27) reported that
intravenous ANG II infusion induced continuous low-ampli-
tude discharges in renal sympathetic nerve activity. These
authors stated that ANG-induced sympathetic activation was
still present after ganglionic blockade but was abolished by the
ANG AT1 receptor antagonist losartan. Further studies showed
that ANG II increased, by means of AT1 receptors, cytosolic
calcium influx in postganglionic sympathetic neurons (28).
Although data from Ma et al. (27, 28) suggest that ANG II
signaling is critical in the modulation of sympathetic neural
activity and might predict a reduction in sympathetic nerve
activity after disruption of AT1a receptors, our results point to
another direction. Both 1-adrenergic antagonist and auto-
nomic ganglion blockade elicited a fall in AP that was much
more pronounced in AT1a / mice compared with their
counterparts. Although the AP response to prazosin in the
control group was not as great as in other studies (23, 25), the
decrease in AP observed 30–60 min after ganglionic blockade
in this group was similar to that found by Janssen et al. (23) in
male Swiss mice. In addition, hexamethonium also elicited a
significantly greater bradycardia in AT1a / mice, support-
ing the idea that these animals have a low intrinsic HR. This
finding is in agreement with data that show that ANG II
regulates intrinsic HR. An intravenous infusion of ANG II
elicited an increase in intrinsic HR, as did endogenous over-
activity of the RAS, observed during the onset of 1-kidney,
1-clip (1K1C) renal hypertension (29, 30). In the coarctation
model of hypertension, there was also an increase in HR that
was mediated by ANG AT1 receptors (4). Taken together,
these findings suggest that removal of ANG AT1a input should
increase sympathetic drive. Indeed, the lack of ANG AT1
signaling in the gene-deletion mice leads to sympathetic com-
pensation to maintain AP for adequate tissue perfusion. Con-
versely, genetically normal mice may use the AT1a receptor
system to counterbalance any change in adrenergic drive to the
vasculature.
With regard to cardiac baroreflex, there is also evidence for
interactions between the RAS and reflex control (5, 20, 42). To
our knowledge, this is the first study to evaluate the influence
of AT1a receptors on baroreflex sensitivity. Surprisingly, there
were no differences in spontaneous baroreflex sensitivity in
AT1a / mice, studied either by sequence or cross-spectral
(-index) analysis. Because central ANG II impairs baroreflex
function through AT1 receptors (5, 20, 42), one would expect
that baroreflexes would be enhanced in mice lacking AT1a
receptors. However, it should be pointed out that baroreflex
sensitivity in the present study was measured under limited
conditions. Rather, a study by Gross et al. (20) suggested that
Fig. 5. Decrease in MAP (
MAP) observed after intraperitoneal injection of
either prasozin or hexamethonium in AT1a / and AT1a / mice. *P 
0.05 compared with AT1a /.
Fig. 6. Heart rate measured before (basal; open bars) and after (intrinsic;
hatched bars) intraperitoneal injection of hexamethonium. bpm, Beats/min.
*P 0.05 compared with basal; **P 0.05 compared with intrinsic heart rate
of AT1a / group.
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AT2 receptors are important in baroreflex control. In AT2 /
mice, the baroreflex index was increased, suggesting that AT2
receptors impaired cardiac baroreflex.
In conclusion, data suggest that ANG AT1a receptors are
required for maintaining normal autonomic control of AP and
HR. The increased fall in pressure elicited by either 1-
adrenergic or autonomic ganglion blockade, as well as the
greater effect of autonomic ganglionic blockade on HR,
strongly suggests that an increased sympathetic drive to the
vasculature may compensate for the lack of ANG AT1a sig-
naling in AT1a / mice. In addition, our results suggest that
ANG AT1a receptors are not required for the maintenance of
normal baroreflex function.
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